Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
11/27/2014 | US20140349994 Novel 2-Amino-4,5,6,8-Tetrahydropyrazolo[3,4-b]Thiazolo [4,5-d]Azepine Derivatives and Their Use as Allosteric Modulators of Metabotropic Glutamate Receptors |
11/27/2014 | US20140349990 Pyrazolopyrrolidine Derivatives and their Use in the Treatment of Disease |
11/27/2014 | US20140349989 Compounds and therapeutic uses thereof |
11/27/2014 | US20140349988 Organonitro thioether compounds and medical uses thereof |
11/27/2014 | US20140349976 Co-administration of pimavanserin with other agents |
11/27/2014 | US20140349965 Compositions and methods for treating neoplastic diseases |
11/27/2014 | US20140349955 Use of fluorine-containing water soluble platinum complex in preparing drugs for prevention and treatment of cancers |
11/27/2014 | US20140349943 Topical formulations of chemerin c15 peptides for the treatment of dermatological conditions |
11/27/2014 | US20140349931 Detection and treatment of breast cancer |
11/27/2014 | US20140349930 Treatment using neublastin polypeptides |
11/27/2014 | US20140349927 Ladostigil Therapy For Immunomodulation |
11/27/2014 | US20140349921 Hcv ns3 protease inhibitors |
11/27/2014 | US20140348959 Formulations and Methods for Treating Ear Conditions |
11/27/2014 | US20140348958 Anticancer Active Ingredient From Guiera Senegalensis |
11/27/2014 | US20140348955 Methods for improving the safety of treating pediatric patients who are candidates for inhaled nitric oxide treatment |
11/27/2014 | US20140348942 Treatments for Gastrointestinal Disorders |
11/27/2014 | US20140348923 Polymeric Drug-Delivery Material, Method For Manufacturing Thereof And Method For Delivery Of A Drug-Delivery Composition |
11/27/2014 | US20140348902 Tcl1 peptides for immunotherapy |
11/27/2014 | US20140348899 Method and composition for treating cystitis |
11/27/2014 | US20140348853 Methods of treating rickettsia using exchange proteins directly activated by camp (epacs) inhibitors |
11/27/2014 | US20140348850 Method for reducing blood pressure using inhibitors of plasma kallikrein |
11/27/2014 | US20140348847 Antibodies against human il-12 |
11/27/2014 | US20140348844 Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficile |
11/27/2014 | US20140348830 Interleukin-6 receptor binding polypeptides |
11/27/2014 | US20140348829 Felinized Antibodies and Methods of Treating Retroviral Infections in Felines |
11/27/2014 | US20140348827 Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof |
11/27/2014 | US20140348821 Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer |
11/27/2014 | US20140348819 Methods of Treating Cancer |
11/27/2014 | US20140348814 Arginne deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment |
11/27/2014 | US20140348801 Treatment of Vocal Cords With Autologous Dermal Fibroblast Formulation |
11/27/2014 | US20140348787 Methods and Compositions for Treating Ear Infections |
11/27/2014 | US20140348786 Beta-mannosylceramide and stimulation of nkt cell anti-tumor immunity |
11/27/2014 | US20140348785 Neutralizing gp41 antibodies and their use |
11/27/2014 | US20140348783 Vaccine immunotherapy for immune suppressed patients |
11/27/2014 | US20140348782 Vaccine immunotherapy for immune suppressed patients |
11/27/2014 | US20140348780 Method of Enhanced Antibiotic Activity Via Chemotaxis |
11/27/2014 | US20140348752 Methods for treating lysosomal acid lipase deficiency in patients |
11/25/2014 | US8895755 Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity |
11/25/2014 | US8895737 Process for preparing antiviral compounds |
11/25/2014 | US8895733 Triazine-oxadiazoles |
11/25/2014 | US8895721 RNA interference mediating small RNA molecules |
11/25/2014 | US8895718 RNA interference mediating small RNA molecules |
11/25/2014 | US8895628 Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use |
11/25/2014 | US8895619 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
11/25/2014 | US8895598 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection |
11/25/2014 | US8895596 Cyclic benzimidazole derivatives useful as anti-diabetic agents |
11/25/2014 | US8895586 Methods of treating emesis |
11/25/2014 | US8895583 Soluble guanylate cyclase activators |
11/25/2014 | US8895581 1H-imidazo[4,5-c]quinolines |
11/25/2014 | US8895576 Methods of use of cyclopamine analogs |
11/25/2014 | US8895575 1 H-pyrrolo[2,3-b]pyridine derivatives |
11/25/2014 | US8895555 Methods of treating intestinal diseases and inflammatory conditions related to HIV-AIDS |
11/25/2014 | US8895549 Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
11/25/2014 | US8895547 Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
11/25/2014 | US8895546 Administration of benzodiazepine compositions |
11/25/2014 | US8895540 Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
11/25/2014 | US8895539 Pregnancy hormone combination for treatment of autoimmune diseases |
11/25/2014 | US8895538 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic |
11/25/2014 | US8895535 Pyrrolidinones as MetAP-2 inhibitors |
11/25/2014 | US8895533 Starch derivative mixtures |
11/25/2014 | US8895532 Use of hyaluronic acid for the preparation of compositions intended for improving in particular the protective function of the skin, the eye and the mucous membranes |
11/25/2014 | US8895529 Antisense modulation of fibroblast growth factor receptor 4 expression |
11/25/2014 | US8895521 Methods and compositions for the treatment of uveitis |
11/25/2014 | US8895509 MIR-200 family induces mesenchymal-to-epithelial transition (MET) in ovarian cancer cells |
11/25/2014 | US8895502 β2-glycoprotein I peptide inhibitors |
11/25/2014 | US8895501 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
11/25/2014 | US8895282 Use of a substance for manufacturing of a medicament for treatment of common cold |
11/25/2014 | US8895081 Formulation for treatment of dry mouth and mouth sores |
11/25/2014 | US8895079 Combinations of botanical extracts for promoting cardiovascular health |
11/25/2014 | US8895075 Herbomineral formulation for treating sickle cell disease |
11/25/2014 | US8895074 Therapeutic application of parenteral krill oil |
11/25/2014 | US8895070 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
11/25/2014 | US8895065 Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof |
11/25/2014 | US8895063 Oral dosage form comprising an antimisuse system |
11/25/2014 | US8895061 Compositions comprising carisoprodol and methods of use thereof |
11/25/2014 | US8895033 Sustained release formulations using non-aqueous carriers |
11/25/2014 | US8895018 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction |
11/25/2014 | US8895010 Antibody polypeptides that antagonize CD40L |
11/25/2014 | US8895001 Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers |
11/25/2014 | US8894996 Immunoadjuvant composition and use thereof |
11/25/2014 | US8894994 Modified beta-lactamases and methods and uses related thereto |
11/25/2014 | US8894991 Canine probiotic Lactobacilli |
11/25/2014 | US8894990 Method for treating psoriatic arthritis by administering an anti-IL-12 antibody |
11/25/2014 | US8894989 PARP inhibitor compounds, compositions and methods of use |
11/25/2014 | US8894988 Tamper resistant dosage forms |
11/25/2014 | US8894987 Tamper resistant dosage forms |
11/25/2014 | US8894979 Composition containing at least one C7 sugar for alopecia treatment, cosmetic treatment of hair and nails, and care of hair, eyelashes, or nails |
11/25/2014 | US8894977 Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound |
11/20/2014 | US20140343347 Methods and related compositions for the treatment of cancer |
11/20/2014 | US20140343167 Use of citral for treating focal segmental glomerulosclerosis |
11/20/2014 | US20140343124 Method for reducing expression of downregulated in renal cell carcinoma in malignant gliomas |
11/20/2014 | US20140343119 4-hydroxybutyric acid analogs |
11/20/2014 | US20140343118 Methods of treatment using arylcyclopropylamine compounds |
11/20/2014 | US20140343092 Pyrrolopyridinone Compounds And Methods For Treating HIV |
11/20/2014 | US20140343091 Beta2-adrenoceptor agonists |
11/20/2014 | US20140343077 Hepatitis c inhibitor compounds |
11/20/2014 | US20140343076 Pharmaceutical compositions of lurasidone |
11/20/2014 | US20140343071 Compositions and methods for treating cancer |
11/20/2014 | US20140343069 Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
11/20/2014 | US20140343057 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors |